Samplimy secures KTH Ventures backing for sampling technology
The startup builds painless at-home devices to extract blood and tissue fluids, advancing diagnostics and drug research.
See the latest news and media coverage for Samplimy. We track all announcements, press releases, and industry mentions in real time, all in one place.
Microsampling device developer for blood and interstitial fluid
samplimy.comLast updated
In short: Samplimy secured KTH Ventures backing and a Vinnova grant to advance its painless at-home blood and tissue fluid sampling technology.
The startup builds painless at-home devices to extract blood and tissue fluids, advancing diagnostics and drug research.
They express gratitude to Life Science Cluster Flemingsberg for the opportunity to pitch to investors and entrepreneurs.
The grant supports knowledge-intensive Swedish startups with high innovation potential. It accelerates painless home-based blood and interstitial fluid sampling for preventive healthcare.
Samplimy is selected as a Top 8 company to pitch for Disruptor of the Year. It will exhibit and meet investors, entrepreneurs, and academic partners.
In this edition, we feature Patrik Nilsson, CEO of Samplimy Medical AB, a pioneering medtech company transforming the way blood and interstitial fluid samples are...
Track Samplimy and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.